The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy

Anticancer agents can effectively treat several types of cancers but are often limited in clinical settings due to various adverse effects. In particular, nausea and vomiting are serious side effects that markedly reduce the patients' quality of life. Accordingly, the development of novel antie...

Full description

Bibliographic Details
Main Authors: Hiroto Yanagawa, Yoshihisa Koyama, Yuki Kobayashi, Hikaru Kobayashi, Shoichi Shimada
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580822001637